These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33205707)

  • 21. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.
    Heldermon CD; Hennig AK; Ohlemiller KK; Ogilvie JM; Herzog ED; Breidenbach A; Vogler C; Wozniak DF; Sands MS
    PLoS One; 2007 Aug; 2(8):e772. PubMed ID: 17712420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice.
    Malinowska M; Wilkinson FL; Bennett W; Langford-Smith KJ; O'Leary HA; Jakobkiewicz-Banecka J; Wynn R; Wraith JE; Wegrzyn G; Bigger BW
    Mol Genet Metab; 2009 Nov; 98(3):235-42. PubMed ID: 19632871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral nervous system neuropathology and progressive sensory impairments in a mouse model of Mucopolysaccharidosis IIIB.
    Fu H; Bartz JD; Stephens RL; McCarty DM
    PLoS One; 2012; 7(9):e45992. PubMed ID: 23049915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations.
    Jones MZ; Alroy J; Downs-Kelly E; Lucas RE; Kraemer SA; Cavanagh KT; King B; Hopwood JJ
    J Mol Neurosci; 2004; 24(2):277-91. PubMed ID: 15456941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB.
    Petrova R; Patil AR; Trinh V; McElroy KE; Bhakta M; Tien J; Wilson DS; Warren L; Stratton JR
    Sci Rep; 2023 Oct; 13(1):16699. PubMed ID: 37794029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
    Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
    Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.
    Wang RY; Aminian A; McEntee MF; Kan SH; Simonaro CM; Lamanna WC; Lawrence R; Ellinwood NM; Guerra C; Le SQ; Dickson PI; Esko JD
    Mol Genet Metab; 2014 Aug; 112(4):286-93. PubMed ID: 24951454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs.
    Yogalingam G; Pollard T; Gliddon B; Jolly RD; Hopwood JJ
    Genomics; 2002 Feb; 79(2):150-3. PubMed ID: 11829484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs.
    Raj K; Ellinwood NM; Giger U
    Sci Rep; 2020 Feb; 10(1):3170. PubMed ID: 32081995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
    Yogalingam G; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.
    Truxal KV; Fu H; McCarty DM; McNally KA; Kunkler KL; Zumberge NA; Martin L; Aylward SC; Alfano LN; Berry KM; Lowes LP; Corridore M; McKee C; McBride KL; Flanigan KM
    Mol Genet Metab; 2016 Nov; 119(3):239-248. PubMed ID: 27590925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models.
    Rintz E; Podlacha M; Cyske Z; Pierzynowska K; Węgrzyn G; Gaffke L
    Neurotherapeutics; 2023 Jan; 20(1):254-271. PubMed ID: 36344724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue.
    Hamano K; Hayashi M; Shioda K; Fukatsu R; Mizutani S
    Acta Neuropathol; 2008 May; 115(5):547-59. PubMed ID: 18060551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery.
    Fu H; Samulski RJ; McCown TJ; Picornell YJ; Fletcher D; Muenzer J
    Mol Ther; 2002 Jan; 5(1):42-9. PubMed ID: 11786044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII.
    Hordeaux J; Deniaud J; Bemelmans I; Bertrand L; Moreau S; Amiaud J; Wyers M; Cherel Y; Colle MA
    Vet Pathol; 2011 May; 48(3):616-26. PubMed ID: 20930106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of therapeutic protein for prevention of neurodegenerative changes: comparison of different CSF-delivery methods.
    Marshall NR; Hassiotis S; King B; Rozaklis T; Trim PJ; Duplock SK; Winner LK; Beard H; Snel MF; Jolly RD; Hopwood JJ; Hemsley KM
    Exp Neurol; 2015 Jan; 263():79-90. PubMed ID: 25246230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB.
    Okur I; Ezgu F; Giugliani R; Muschol N; Koehn A; Amartino H; Harmatz P; de Castro Lopez MJ; Couce ML; Lin SP; Batzios S; Cleary M; Solano M; Peters H; Lee J; Nestrasil I; Shaywitz AJ; Maricich SM; Kuca B; Kovalchin J; Zanelli E
    J Pediatr; 2022 Oct; 249():50-58.e2. PubMed ID: 35709957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB.
    Tse DY; Lotfi P; Simons DL; Sardiello M; Wu SM
    Sci Rep; 2015 Nov; 5():17143. PubMed ID: 26607664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanfilippo syndrome type B: Analysis of patients diagnosed by the MPS Brazil Network.
    Montenegro YHA; de Souza CFM; Kubaski F; Trapp FB; Burin MG; Michelin-Tirelli K; Leistner-Segal S; Facchin ACB; Medeiros FS; Giugliani L; Ribeiro EM; Lourenço CM; Cardoso-Dos-Santos AC; Ribeiro MG; Kim CA; Castro MAA; Embiruçu EK; Steiner CE; Moreira MLC; Montano HQ; Baldo G; Giugliani R
    Am J Med Genet A; 2022 Mar; 188(3):760-767. PubMed ID: 34806811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.